We further investigated the expression of NAD-synthesis enzymes in a very rare cohort of three patient-derived IDH1-mutant glioma cell models that have native homozygous IDH1R132H and additionally five patient-derived glioblastoma cell lines with IDH1-wildtype status. This evidence concerns the gene IDH1 and central nervous system cancer.